COMPASS PATHWAYS PLC -
5.3000
07-November-24 15:59:59
15 minutes delayed
Stocks
+0.5700
+12.05%
Today's range
4.7500 - 5.4700
ISIN
N/A
Source
NASDAQ
-
COMPASS Pathways plc to announce second quarter 2022 financial results on 4 August 2022
26 Jul 2022 08:00:00 By Nasdaq GlobeNewswire
-
COMPASS Pathways appoints Kabir Nath as Chief Executive Officer
19 Jul 2022 08:00:00 By Nasdaq GlobeNewswire
-
23 May 2022 07:00:00 By Nasdaq GlobeNewswire
-
12 May 2022 08:00:00 By Nasdaq GlobeNewswire
-
COMPASS Pathways plc announces first quarter 2022 financial results and business highlights
10 May 2022 07:00:00 By Nasdaq GlobeNewswire
-
COMPASS Pathways to fund study of COMP360 psilocybin in autistic adults
09 May 2022 07:00:00 By Nasdaq GlobeNewswire
-
COMPASS Pathways plc to announce first quarter 2022 financial results on 10 May 2022
03 May 2022 08:00:00 By Nasdaq GlobeNewswire
-
03 May 2022 07:00:00 By Nasdaq GlobeNewswire
-
20 Apr 2022 07:00:00 By Nasdaq GlobeNewswire
-
COMPASS Pathways to participate in Needham Healthcare conference
04 Apr 2022 08:00:00 By Nasdaq GlobeNewswire
-
COMPASS Pathways and partners launch The Centre for Mental Health Research and Innovation, in the UK
24 Mar 2022 05:00:00 By Nasdaq GlobeNewswire
-
COMPASS Pathways to participate in Cowen and Roth investor conferences
02 Mar 2022 07:00:00 By Nasdaq GlobeNewswire
-
24 Feb 2022 07:12:48 By Nasdaq GlobeNewswire
-
17 Feb 2022 12:20:59 By Nasdaq GlobeNewswire
-
19 Jan 2022 07:00:00 By Nasdaq GlobeNewswire
-
COMPASS Pathways to participate in H.C. Wainwright investor conference
10 Jan 2022 07:00:00 By Nasdaq GlobeNewswire
-
COMP360 psilocybin study of 89 healthy participants published in Journal of Psychopharmacology
04 Jan 2022 07:00:00 By Nasdaq GlobeNewswire
-
COMPASS Selected for Addition to NASDAQ Biotechnology Index
17 Dec 2021 07:00:00 By Nasdaq GlobeNewswire
-
COMPASS Pathways announces changes in Executive Team
16 Dec 2021 07:40:00 By Nasdaq GlobeNewswire
-
13 Dec 2021 07:00:02 By Nasdaq GlobeNewswire